David J. Ballance
26Patents
12h-index
26Co-inventors
81Inventor score
Filing activity: Feb 14, 1992 → Jun 22, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7141547B2 | Albumin fusion proteins comprising GLP-1 polypeptides | Chemistry; Metallurgy | 197 | Expired |
| US5766883A | Polypeptides | Chemistry; Metallurgy | 111 | Expired |
| US7592010B2 | Albumin fusion proteins | Chemistry; Metallurgy | 94 | Active |
| US7045318B2 | Recombinant fusion proteins to growth hormone and serum albumin | Chemistry; Metallurgy | 66 | Expired |
| US5380712A | Truncated human serum albumin polypeptides as plasma expanding agents | Human Necessities | 65 | Expired |
| US7482013B2 | Albumin fusion proteins | Emerging Cross-Sectional Technologies | 63 | Expired |
| US8012464B2 | G-CSF-albumin fusion proteins | Chemistry; Metallurgy | 29 | Active |
| US7799759B2 | Albumin fusion proteins | Chemistry; Metallurgy | 28 | Active |
| US7785599B2 | Albumin fusion proteins | Emerging Cross-Sectional Technologies | 26 | Active |
| US7550432B2 | Recombinant fusion proteins to growth hormone and serum albumin | Chemistry; Metallurgy | 21 | Active |
| US8158579B2 | Fusion protein of an exendin to modified transferrin | Chemistry; Metallurgy | 20 | Active |
| US7867972B2 | Fusion protein of exendin-4 to a transferrin (Tf) polypeptide | Chemistry; Metallurgy | 19 | Active |
| US7993877B2 | Process for the purification of recombinant albumin | Chemistry; Metallurgy | 9 | Active |
| US9775888B2 | Treatment with factor ix-albumin fusion protein | Emerging Cross-Sectional Technologies | 5 | Active |
| US8946156B2 | Albumin Fusion Proteins | Emerging Cross-Sectional Technologies | 2 | Active |
| US10688156B2 | Methods and compositions for treating muscle disease and disorders | Human Necessities | 2 | Active |
| US6290953A | Modulation of cellular proliferation with thymidine phosphorylase | Human Necessities | 1 | Expired |
| US10080785B2 | Albumin fusion proteins | Emerging Cross-Sectional Technologies | 1 | Active |
| US10722590B2 | ELP fusion proteins for controlled and sustained release | Chemistry; Metallurgy | 0 | Active |
| US9029102B2 | Process for the purification of recombinant albumin | Chemistry; Metallurgy | 0 | Active |
| US8642542B2 | Recombinant fusion proteins to growth hormone and serum albumin | Chemistry; Metallurgy | 0 | Active |
| US9821039B2 | Albumin fusion proteins | Emerging Cross-Sectional Technologies | 0 | Active |
| US9555344B2 | Process for the purification of recombinant albumin | Chemistry; Metallurgy | 0 | Active |
| US11052132B2 | Methods and compositions for treating cystic fibrosis | Human Necessities | 0 | Active |
| US11266719B2 | Methods and compositions for treating muscle disease and disorders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.